Evidence-Based Laboratory Medicine: Laboratory Medicine Best Practices Systematic Review Recommendations Evaluation

The summary for the Evidence-Based Laboratory Medicine: Laboratory Medicine Best Practices Systematic Review Recommendations Evaluation grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the Centers for Disease Control and Prevention, which is the U.S. government agency offering this grant.
Evidence-Based Laboratory Medicine: Laboratory Medicine Best Practices Systematic Review Recommendations Evaluation: The purpose of the project is to evaluate the clinical laboratory best practice recommendation for reducing blood sample hemolysis rates developed through the Laboratory Medicine Best PracticesTM (LMBPTM) Initiative of the Centers for Disease Control and Prevention. This recommendation was the product of a systematic review for evidence of effectiveness for practices to reduce hemolysis and was developed using the A6 Method established through the LMBPTM Initiative. The current study seeks to measure the extent of improvement that results from implementation of this evidence-based best practice recommendation compared to existing (current) practices to reduce hemolysis. The design of the recommendation evaluation plan should be based on the A6 Method, described elsewhere in this document, and consider evidence of effectiveness as defined by laboratory quality indicators, patient outcomes, and cost analyses consistent with national health care priorities for improving public health. The LMBPTM recommendation for reduction of blood sample hemolysis rates will be evaluated through replication as described. One applicant will be awarded. This single award can be implemented as a study conducted in a single institution, measuring one or more settings within the institution, or multiple settings within affiliated facilities of a health system. The budget should reflect study design complexity. The purpose is limited to quality improvement associated with delivering healthcare, and the associated measuring and reporting of performance data.
Federal Grant Title: Evidence-Based Laboratory Medicine: Laboratory Medicine Best Practices Systematic Review Recommendations Evaluation
Federal Agency Name: Centers for Disease Control and Prevention
Grant Categories: Health
Type of Opportunity: Discretionary
Funding Opportunity Number: CDC-RFA-OE13-1303
Type of Funding: Cooperative Agreement
CFDA Numbers: 93.064
CFDA Descriptions: Laboratory Training, Evaluation, and Quality Assurance Programs
Current Application Deadline: May 30, 2013
Original Application Deadline: May 30, 2013
Posted Date: Apr 17, 2013
Creation Date: Apr 17, 2013
Archive Date: Jun 29, 2013
Total Program Funding: $400,000
Maximum Federal Grant Award: $200,000
Minimum Federal Grant Award: $0
Expected Number of Awards: 1
Cost Sharing or Matching: No
Applicants Eligible for this Grant
Others (see text field entitled "Additional Information on Eligibility" for clarification)
Additional Information on Eligibility
C. Eligibility Information 1. Eligible Applicants: - American Indian/Alaska Native tribal governments (federally recognized or state-recognized) - American Indian/Alaska native tribally designated organizations - Alaska Native health corporations - Colleges - Community-based organizations - Faith-based organizations - Hospitals - Nonprofit with 501C3 IRS status (other than institution of higher education) - Nonprofit without 501C3 IRS status (other than institution of higher education) - Political subdivisions of States (in consultation with States) - Research institutions (that will perform activities deemed as non-research) - State and local governments or their Bona Fide Agents (this includes the District of Columbia, the Commonwealth of Puerto Rico, the Virgin Islands, the Commonwealth of the Northern Marianna Islands, American Samoa, Guam, the Federated States of Micronesia, the Republic of the Marshall Islands, and the Republic of Palau) . - Tribal epidemiology centers - Universities - Urban Indian health organizations
Grant Announcement Contact
CDC Procurement and Grants Office (PGO) Technical Information Management Section (TIMS) Phone: 770-488-2700 E-mail: pgotim@cdc.gov
Technical Information Management Section (TIMS) [pgotim@cdc.gov]
Similar Government Grants
PPHF 2017: Immunization Grants-CDC Partnership: Strengthening Public Health Laboratories-f...
Improving the Impact of Laboratory Practice: A New Paradigm for Metrics, CSELS and DLPSS
Improving Waived Testing Performance and Outcomes through Partnerships
Use of a Medical Data Warehouse in a Laboratory Quality Improvement Initiative that Links ...
Reduction of Hemolysis in Specimens from Patients in Emergency Departments: Evaluation of ...
Improvement of Laboratory Testing and Services in the United States
Initiative to Integrate Clinical Laboratories into Public Health Testing
Developing an Agenda for Laboratory Practice Research Based on the 2007 Institute: Managin...
More Grants from the Centers for Disease Control and Prevention
93.067
Surveillance and Response to Avian and Pandemic Influenza by National Health Authorities o...
Technical Assistance to Support Comprehensive Combination HIV Prevention, Care and Treatme...
Strengthening Ebola rapid detection and response capacity through community based surveill...
test2

FederalGrants.com is not endorsed by, or affiliated with, any government agency. Copyright ©2019 FederalGrants.com